Antivirals and antibiotics for influenza in the United States, 1995-2002
- 14 January 2005
- journal article
- research article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 14 (8) , 531-536
- https://doi.org/10.1002/pds.1067
Abstract
To measure the rates of antiviral and antibiotic prescribing for patients diagnosed with influenza in the United States. We performed a retrospective analysis of visits to ambulatory clinics and emergency departments in the National Ambulatory Medical Care Survey (NAMCS) and the National Hospital Ambulatory Medical Care Survey (NHAMCS) with a diagnosis of influenza that occurred in seven influenza seasons between 1 October 1995 and 31 May 2002 (n=1216). There were an estimated 22 million visits (95%CI, 17--26 million visits) with a diagnosis of influenza to community ambulatory clinics (88% of visits), hospital ambulatory clinics (3%) and emergency departments (9%) in the United States between the 1995--1996 and the 2001--2002 influenza seasons, inclusive. The sample was 63% adults, 44% male and 84% white. Physicians prescribed antivirals in 19% of visits and antibiotics not associated with an antibiotic-appropriate diagnosis in 26% of visits. In multivariable modeling, independent predictors of antiviral prescribing were adult age (OR, 2.1; 95%CI, 1.1--4.0) and Medicare insurance (OR, 0.1 compared to private insurance; 95%CI, 0.0--0.6). Antiviral prescribing was marginally associated with influenza season (OR, 1.2 per influenza season; 95%CI, 1.0--1.4). Independent predictors of antibiotic prescribing were influenza season (OR, 0.8 per influenza season; 95%CI, 0.7--0.9), male sex (OR, 0.6; 95%CI, 0.4--0.9), adult age (OR, 2.3; 95%CI, 1.2--4.2) and emergency department visits (OR, 0.5 compared to community ambulatory visits; 95%CI, 0.3--0.8). Physicians prescribed antiviral medications to 19% of patients they diagnosed with influenza; the proportion that would have been clinically appropriate is unknown. In contrast, physicians prescribed apparently inappropriate antibiotics to 26% of these same patients, a rate that, encouragingly, decreased over time.Keywords
Funding Information
- Dr. Linder is supported by a Career Development Award from the Agency for Healthcare Research and Quality (K08 HS014563)
This publication has 23 references indexed in Scilit:
- Management of Influenza in Adults Older than 65 Years of Age: Cost-Effectiveness of Rapid Testing and Antiviral TherapyAnnals of Internal Medicine, 2003
- Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trialsBMJ, 2003
- Use of Oseltamivir During Influenza Outbreaks in Ontario Nursing Homes, 1999–2000Journal of the American Geriatrics Society, 2002
- Zanamivir for the Treatment of Influenza A and B Infection in High-Risk PatientsArchives of internal medicine (1960), 2001
- Prevention and Treatment of InfluenzaNew England Journal of Medicine, 2000
- Impact of Zanamivir on Antibiotic Use for Respiratory Events Following Acute Influenza in Adolescents and AdultsArchives of internal medicine (1960), 2000
- Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trialThe Lancet, 2000
- Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute InfluenzaJAMA, 2000
- Randomized, placebo-controlled studies of inhaled zanamivir in the treatment of influenza A and B: pooled efficacy analysisJournal of Antimicrobial Chemotherapy, 1999
- Sequential Outbreak of Influenza A and B in a Nursing Home: Efficacy of Vaccine and AmantadineJournal of the American Geriatrics Society, 1996